Megan Davis, MD
Hospice and Palliative Medicine · Fayetteville, ARNPI 1255623609
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $8,287 of the $11,249 with a category attached, or 73.7%. Merck accounts for 75.4% of it on its own, with 48 other manufacturers making up the rest. 2025 is the largest year on record at $8,580, more than ten times the $823 reported in 2019. Among hospice and palliative medicine clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 202 payments — averaging $55.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$8K
- Johnson & Johnson$398
- Novartis$241
- Eisai Inc.$216
- Takeda Pharmaceuticals U.S.A., Inc.$199
- Regeneron Healthcare Solutions, Inc.$140
- plus $2K from 43 others
What the payments were for
- Travel & lodging$8,28774%
- Food & beverage$2,94926%
- Education$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$11,249 in reported general payments places this provider in the 95th percentile of 20 hospice and palliative medicine providers in Arkansas.
See all hospice and palliative medicine providers in Arkansas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 48 | $23,779 |
| Fentanyl | 279 | $22,499 |
| BelbucaBuprenorphine Hcl | 25 | $14,924 |
| Buprenorphine | 55 | $12,826 |
| ButransBuprenorphine | 24 | $11,638 |
| Oxycodone Hcl | 567 | $7,430 |
| OxycontinOxycodone Hcl | 20 | $6,800 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 250 | $5,394 |
| Gabapentin | 192 | $3,128 |
| Duloxetine Hcl | 144 | $2,690 |
| Morphine Sulfate ErMorphine Sulfate | 96 | $2,267 |
| Pregabalin | 155 | $1,882 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 108 | $1,839 |
| Morphine Sulfate | 91 | $1,738 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 34 | $1,408 |
Paid to pharmacies, not to this prescriber.
Other hospice and palliative medicine in Fayetteville
- Juan LombeidaFayetteville$3K
- Leslie LandrumFayetteville$415
- Roger MontgomeryFayetteville$38
- Mikeal LoveFayetteville$12
- Andrea AllenNorth Little Rock$971
- Carrie HydeLittle Rock$373
- Jaclynn EliasLittle Rock$346
- Masil GeorgeLittle Rock$143
- David SmithLittle Rock$143
- Clark SmithLittle Rock$114
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.